NASDAQ: SY
So Young International Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their SY stock forecasts and price targets.

Forecast return on equity

Is SY forecast to generate an efficient return?

Company
82.8%
Industry
15.21%
Market
358.39%
SY's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SY forecast to generate an efficient return on assets?

Company
52.31%
Industry
13.29%
SY is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SY earnings per share forecast

What is SY's earnings per share in the next 2 years based on estimates from 5 analysts?

Avg 1 year Forecast
$0.47
Avg 2 year Forecast
$2.53

SY revenue forecast

What is SY's revenue in the next 2 years based on estimates from 5 analysts?

Avg 1 year Forecast
$2.5B+1,119.73%
Avg 2 year Forecast
$3.5B+1,617.47%
SY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SY revenue growth forecast

How is SY forecast to perform vs Health Information Services companies and vs the US market?

Company
1,119.73%
Industry
14.63%
Market
1,566.11%
SY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SY vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
SY$3.07N/AN/A
TBRG$20.16$23.00+14.09%Hold
SPOK$13.56N/AN/A
DH$2.38$4.25+78.57%Hold
CARL$13.23$20.25+53.06%Strong Buy

So Young International Stock Forecast FAQ

What is SY's earnings growth forecast for 2026-2027?

(NASDAQ: SY) So Young International's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 92.48%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 3,307.52%.

So Young International's earnings in 2026 is -$104,076,966.On average, 5 Wall Street analysts forecast SY's earnings for 2026 to be $35,724,018, with the lowest SY earnings forecast at $7,886,723, and the highest SY earnings forecast at $64,381,409.

In 2027, SY is forecast to generate $194,278,567 in earnings, with the lowest earnings forecast at $184,851,290 and the highest earnings forecast at $198,057,143.

If you're new to stock investing, here's how to buy So Young International stock.

What is SY's revenue growth forecast for 2026-2027?

(NASDAQ: SY) So Young International's forecast annual revenue growth rate of 1,119.73% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 14.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,566.11%.

So Young International's revenue in 2026 is $201,109,410.On average, 5 Wall Street analysts forecast SY's revenue for 2026 to be $188,009,044,355, with the lowest SY revenue forecast at $156,431,495,935, and the highest SY revenue forecast at $215,677,721,490.

In 2027, SY is forecast to generate $264,730,223,890 in revenue, with the lowest revenue forecast at $214,987,920,675 and the highest revenue forecast at $309,413,987,795.

What is SY's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: SY) forecast ROA is 52.31%, which is higher than the forecast US Health Information Services industry average of 13.29%.

What is SY's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: SY) So Young International's current Earnings Per Share (EPS) is -$1.02. On average, analysts forecast that SY's EPS will be $0.47 for 2026, with the lowest EPS forecast at $0.10, and the highest EPS forecast at $0.84. In 2027, SY's EPS is forecast to hit $2.53 (min: $2.41, max: $2.58).

What is SY's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: SY) forecast ROE is 82.8%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.